The Oral Calcilytic Encaleret Decreased the Fractional Excretion of Calcium in Individuals with Post-surgical Hypoparathyroidism: Preliminary Findings from an Ongoing Open-label Phase 2 Study

被引：0
|
作者：
Gafni, Rachel I. [1 ]
Roszko, Kelly L. [1 ]
Li, Xiaobai [2 ]
Ferguson, Elizabeth A. [1 ]
Moore, Casey A. [1 ]
Pozo, Karen A. [1 ]
Ampuero, Kimberly T. [1 ]
Meadows, Rita E. J. [1 ]
Sridhar, Ananth V. [3 ]
Mathew, Arun S. [3 ]
Roberts, Mary Scott [3 ]
Adler, Scott H. [3 ]
Nemeth, Edward F. [4 ]
Collins, Michael T. [1 ]
机构：
[1] Nat Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA
[2] NIH, Biostat & Clin Epidemiol, Clin Ctr, Bethesda, MD USA
[3] Calcilytix Therapeut Inc, San Francisco, CA USA
[4] MetisMedica, Montreal, PQ, Canada
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SUN-LB 591
引用
收藏
页码：360 / 361
页数：2
相关论文
共 50 条
  • [1] Effects of Encaleret on Corrected QT Interval in Autosomal Dominant Hypocalcemia Type 1: Early Results From an Ongoing Phase 2b, Open-Label, Dose-Ranging Study
    Hartley, Iris
    Gafni, Rachel
    Roszko, Kelly
    Pozo, Karen
    Collins, Michael T.
    Nemeth, Edward
    Sani-Grosso, Ramei
    Sridhar, Ananth
    Stapleton, Lyndsay
    Roberts, Mary Scott
    Fox, Jonathan
    CIRCULATION, 2021, 144
  • [2] Efficacy of bovine lactoferrin in the post-surgical treatment of patients suffering from bisphosphonate-related osteonecrosis of the jaws: an open-label study
    Francesco Calvani
    Antimo Cutone
    Maria Stefania Lepanto
    Luigi Rosa
    Valentino Valentini
    Piera Valenti
    BioMetals, 2018, 31 : 445 - 455
  • [3] Efficacy of bovine lactoferrin in the post-surgical treatment of patients suffering from bisphosphonate-related osteonecrosis of the jaws: an open-label study
    Calvani, Francesco
    Cutone, Antimo
    Lepanto, Maria Stefania
    Rosa, Luigi
    Valentini, Valentino
    Valenti, Piera
    BIOMETALS, 2018, 31 (03) : 445 - 455
  • [4] Preliminary Results from an Open-Label, Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia (CMML)
    Patnaik, Mrinal M.
    Sallman, David A.
    Sekeres, Mikkael A.
    Luger, Selina
    Bejar, Rafael
    Hobbs, Gabriela S.
    DeZern, Amy E.
    Bolognese, James
    Traynor, Mary
    Mishra, Vishnu
    Wages, David
    Gualberto, Antonio
    Scholz, Catherine
    Padron, Eric
    BLOOD, 2017, 130
  • [5] Denosumab in the treatment of giant cell tumor of bone: preliminary results from an open-label phase 2 study
    Thomas, D.
    Chawla, S.
    Skubitz, K.
    Staddon, A.
    Henshaw, R.
    Smith, J.
    Ye, Z.
    Sohn, W.
    Jun, S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 66 - 66
  • [6] Preliminary findings from a phase I, open-label, dose-finding study of SNB-101 in patients with advanced solid tumors
    Sang, Y. B.
    Kim, Y.
    Lee, M. A.
    Rha, S. Y.
    Jung, M.
    Lee, C-K.
    Park, Y. H.
    Heo, D.
    Kim, A.
    Kim, J.
    Kim, J-H.
    ANNALS OF ONCOLOGY, 2023, 34 : S474 - S474
  • [7] ENCOURAGING PRELIMINARY DATA IN ONGOING OPEN-LABEL PHASE 1/2 STUDY OF SAFETY AND EFFICACY OF MELFLUFEN AND *DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED-REFRACTORY MULTIPLE MYELOMA
    Magarotto, V.
    Sonneveld, P.
    Voorhees, P.
    Paba-Prada, C.
    Plesner, T.
    Mellqvist, U. H.
    Byrne, C.
    Harmenberg, J.
    Nordstrom, E.
    Palumbo, A.
    Richardson, P.
    HAEMATOLOGICA, 2015, 100 : 89 - 89
  • [8] Pulmonary resectable mets of osteosarcoma with anti-angiogenic and chemotherapy (PROACH), an open-label, single-arm phase II clinical trial: The pathological study of the post-surgical specimens
    Bao, Q.
    Zhang, Z.
    Wen, J.
    Yang, X.
    Shen, Y.
    Zhang, W.
    ANNALS OF ONCOLOGY, 2024, 35
  • [9] Phase 3 Trial of an Oral CXCR4 Antagonist, Mavorixafor, for Treatment of Patients With WHIM Syndrome: Preliminary Results From Ongoing Open-Label Extension Period of Continuous Mavorixafor Treatment
    Tarrant, Teresa
    Badolato, Raffaele
    Donadieu, Jean
    Dubuc, Susan
    Hu, Yanping
    Jiang, Honghua
    Li, Sunny
    Steiner, Deborah
    Yan, Tina
    Arbet-Engels, Christophe
    CLINICAL IMMUNOLOGY, 2024, 262
  • [10] N-Acetylmannosamine (ManNAc) for the Treatment of GNE Myopathy: 18-Month Preliminary Results from a Phase 2 Open-Label Study
    Huizing, Marjan
    Class, Bradley
    Quintana, Melanie
    Slota, Christina
    Leoyklang, Petcharat
    Glowacki, Ashleigh
    Bradley, Kennan
    Ciccone, Carla
    Malicdan, May Christine V.
    Berry, Scott M.
    Gahl, William A.
    Carrillo, Nuria
    GLYCOBIOLOGY, 2017, 27 (12) : 1219 - 1219
12345